Skip to content
HowShorted

NRX Pharmaceuticals, Inc. short interest in 2026

In 2026, NRX Pharmaceuticals, Inc.'s disclosed short interest ran from 12.56% of shares outstanding on 15 Jan 2026 to 22.57% on 15 Sep 2026, a change of +10.01 percentage points. The year's high was 22.57% on 15 Sep 2026 and its low 7.59% on 31 Mar 2026, averaging 13.99% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.27 days on 15 Sep 2026. Full history: NRX Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for NRX Pharmaceuticals, Inc. in 2026

2026 in figures

Start of year
12.56% (15 Jan 2026)
End of year
22.57% (15 Sep 2026)
Change
+10.01 pp
High
22.57% (15 Sep 2026)
Low
7.59% (31 Mar 2026)
Average
13.99%
Highest days to cover
16.27 (15 Sep 2026)
SEC filings marked
4

Every report in 2026

NRX Pharmaceuticals, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202612.56%1.30
30 Jan 20269.90%3.78
13 Feb 20269.56%5.37
27 Feb 20268.75%4.72
13 Mar 20269.78%5.12
31 Mar 20267.59%2.3510-K filed
15 Apr 20269.83%4.62
30 Apr 202613.33%3.22
15 May 202612.89%4.1610-Q filed
29 May 202613.73%3.02
15 Jun 202615.76%3.33
30 Jun 202614.89%5.36
15 Jul 202617.11%7.40
31 Jul 202618.09%7.59
14 Aug 202620.03%5.7810-Q filed
31 Aug 202621.47%11.69results (8-K)
15 Sep 202622.57%16.27

See also: NRX Pharmaceuticals, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.